Prof. Paul Franks

Since 2010, Paul Franks has been a professor at the Harvard School of Public Health in Boston and at Lund University in Sweden. From 2016-2021, Paul was deputy-director of one of the world’s leading diabetes research institutions, Lund University Diabetes Center. Paul is also the Scientific Director in Clinical Science at the Novo Nordisk Foundation where he heads-up the precision medicine portfolio.

Paul trained in epidemiology, biostatistics and genetics at the University of Cambridge and the US National Institutes of Health. In the US, Paul worked extensively with Pima and Navajo Indians, two Native American tribes that have been disproportionately burdened by obesity and type 2 diabetes; this seminal research, focusing primarily on the impact of pregnancy diabetes, childhood obesity, and longevity, was ultimately published as the lead article in the New England Journal of Medicine’s edition supporting Michela Obama’s childhood obesity campaign. Paul currently co-chairs the ADA/EASD Precision Medicine in Diabetes Initiative, the leading global effort to translate the vision of precision diabetes medicine into clinical practice.

Paul is one of the world’s most highly-ranked scientists, having published >450 peer-reviewed articles and chapters, many in top-ranking journals including Nature, Science, and New England Journal of Medicine. Much of Paul’s research has focused on optimizing healthy lifestyle recommendations for disease prevention.

Please feel free to share this...